{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:46:47Z","timestamp":1765234007132,"version":"3.41.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03118-3","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T22:48:44Z","timestamp":1746744524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oleogel-mediated Topical Administration of Roflumilast and Paclitaxel as a Synergistic Strategy to Combat Imiquimod-induced Psoriasis"],"prefix":"10.1208","volume":"26","author":[{"given":"Wenxiu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-1982","authenticated-orcid":false,"given":"Hongyu","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"3118_CR1","doi-asserted-by":"publisher","first-page":"175147","DOI":"10.1016\/j.ejphar.2022.175147","volume":"929","author":"G Hari","year":"2022","unstructured":"Hari G, Kishore A, Karkala SRP. Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached? Eur J Pharmacol. 2022;929:175147. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175147.","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"3118_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312. https:\/\/doi.org\/10.1111\/jdv.13854.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"133","key":"3118_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102916","volume":"133","author":"JD Yu","year":"2022","unstructured":"Yu JD, Zhao QX, Wang XY, Zhou H, Hu J, Gu LN, et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133(133): 102916. https:\/\/doi.org\/10.1016\/j.jaut.2022.102916.","journal-title":"J Autoimmun"},{"issue":"2","key":"3118_CR4","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1016\/j.jaad.2022.10.037","volume":"88","author":"RE Kokoska","year":"2023","unstructured":"Kokoska RE, Szeto MD, Dellavalle RP. From the Cochrane Library: Antistreptococcal interventions for guttate and chronic plaque psoriasis. J Am Acad Dermatol. 2023;88(2):E93\u20134. https:\/\/doi.org\/10.1016\/j.jaad.2022.10.037.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3118_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13555-021-00521-z","volume":"11","author":"M Mosca","year":"2021","unstructured":"Mosca M, Hong JL, Hadeler E, Brownstone N, Bhutani T, Liao W. Scalp psoriasis: a literature review of effective therapies and updated recommendations for practical management. Dermatol Ther. 2021;11(3):769\u201397. https:\/\/doi.org\/10.1007\/s13555-021-00521-z.","journal-title":"Dermatol Ther"},{"issue":"2","key":"3118_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","volume":"24","author":"EJ Horn","year":"2010","unstructured":"Horn EJ, Domm S, Katz HI, Lebwohl M, Mrowietz U, Kragballe K, et al. Topical corticosteroids in psoriasis: strategies for improving safety. J Eur Acad Dermatol Venereol. 2010;24(2):119\u201324. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03358.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"18","key":"3118_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3889\/oamjms.2019.414","volume":"7","author":"U Wollina","year":"2019","unstructured":"Wollina U, Tirant M, Vojvodic A, Lotti T. Treatment of psoriasis: novel approaches to topical delivery. Open Access Maced J Med Sci. 2019;7(18):3018\u201325. https:\/\/doi.org\/10.3889\/oamjms.2019.414.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"3118_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","volume":"3","author":"M Wittmann","year":"2013","unstructured":"Wittmann M, Helliwell PS. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther. 2013;3(1):1\u201315. https:\/\/doi.org\/10.1007\/s13555-013-0023-0.","journal-title":"Dermatol Ther"},{"key":"3118_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174258","volume":"906","author":"N Kubota-Ishida","year":"2021","unstructured":"Kubota-Ishida N, Matsuhira T, Kaji C, Kikuchi C, Tabata Y. Anti-inflammatory effects of a novel phosphodiesterase-4 inhibitor, AA6216, in mouse dermatitis models. Eur J Pharmacol. 2021;906: 174258. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174258.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"3118_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jdermsci.2020.09.014","volume":"100","author":"S Kataoka","year":"2020","unstructured":"Kataoka S, Takaishi M, Nakajima K, Sano S. Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation. J Dermatol Sci. 2020;100(3):230\u20133. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.09.014.","journal-title":"J Dermatol Sci"},{"key":"3118_CR11","doi-asserted-by":"publisher","unstructured":"Hanna E, Benchikh El Fegoun A. Anti-TNF alpha-induced paradoxical psoriasis treated with topical roflumilast 0.3. JAAD case reports. 2024;48:115\u20137. https:\/\/doi.org\/10.1016\/j.jdcr.2024.03.015.","DOI":"10.1016\/j.jdcr.2024.03.015"},{"issue":"8","key":"3118_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.36849\/jdd.2020.5370","volume":"19","author":"KA Papp","year":"2020","unstructured":"Papp KA, Gooderham M, Droege M, Merritt C, Osborne DW, Berk DR, et al. Roflumilast cream improves signs and symptoms of plaque psoriasis: results from a phase 1\/2a randomized. Contr Study J Drugs Dermatol. 2020;19(8):734\u201340. https:\/\/doi.org\/10.36849\/jdd.2020.5370.","journal-title":"Contr Study J Drugs Dermatol"},{"issue":"2","key":"3118_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/09546634.2018.1480747","volume":"30","author":"EB Lee","year":"2019","unstructured":"Lee EB, Lebwohl MG, Wu JJ. Treatment of psoriasis with crisaborole. J Dermatol Treat. 2019;30(2):156\u20137. https:\/\/doi.org\/10.1080\/09546634.2018.1480747.","journal-title":"J Dermatol Treat"},{"issue":"7","key":"3118_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jama.2022.22646","volume":"329","author":"B Smith","year":"2023","unstructured":"Smith B, Collier MR, Wu JJ. Roflumilast cream vs vehicle cream and chronic plaque psoriasis. JAMA-J Am Med Assoc. 2023;329(7):594\u20135. https:\/\/doi.org\/10.1001\/jama.2022.22646.","journal-title":"JAMA-J Am Med Assoc"},{"key":"3118_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jdcr.2024.03.002","volume":"47","author":"PS Yamauchi","year":"2024","unstructured":"Yamauchi PS. Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment. JAAD Case Rep. 2024;47:4\u20135. https:\/\/doi.org\/10.1016\/j.jdcr.2024.03.002.","journal-title":"JAAD Case Rep."},{"issue":"2","key":"3118_CR16","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2023.07.1048","volume":"90","author":"PV Engel","year":"2024","unstructured":"Engel PV, Smith B, Javadi SS, Wu JJ. It is time to consider a new topical algorithm for psoriasis. J Am Acad Dermatol. 2024;90(2):e89\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2023.07.1048.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3118_CR17","first-page":"1","volume":"28","author":"A O'Toole","year":"2023","unstructured":"O\u2019Toole A, Gooderham M. Topical roflumilast for plaque psoriasis. Skin Ther Lett. 2023;28(5):1\u20134.","journal-title":"Skin Ther Lett"},{"issue":"5","key":"3118_CR18","doi-asserted-by":"publisher","first-page":"e22745","DOI":"10.1002\/jbt.22745","volume":"35","author":"MH Sharawy","year":"2021","unstructured":"Sharawy MH, El-Awady MS, Makled MN. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model. J Biochem Mol Toxicol. 2021;35(5):e22745. https:\/\/doi.org\/10.1002\/jbt.22745.","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"3118_CR19","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.7150\/thno.30716","volume":"9","author":"PP Wang","year":"2019","unstructured":"Wang PP, Wang HH, Huang QQ, Peng C, Yao L, Chen H, et al. Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics. 2019;9(6):1714\u201327. https:\/\/doi.org\/10.7150\/thno.30716.","journal-title":"Theranostics"},{"issue":"3","key":"3118_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000528128","volume":"14","author":"SS Baglama","year":"2022","unstructured":"Baglama SS, Trajber Horvat A, Peteln I, Jemec GBE. Inflammation of actinic keratoses induced by combination of carboplatin and paclitaxel: two case reports. Case Rep Dermatol. 2022;14(3):362\u20137. https:\/\/doi.org\/10.1159\/000528128.","journal-title":"Case Rep Dermatol"},{"issue":"1","key":"3118_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2012.06.021","volume":"163","author":"BE Kilfoyle","year":"2012","unstructured":"Kilfoyle BE, Sheihet L, Zhang Z, Laohoo M, Kohn J, Michniak-Kohn BB. Development of paclitaxel-TyroSpheres for topical skin treatment. J Control Release. 2012;163(1):18\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2012.06.021.","journal-title":"J Control Release"},{"key":"3118_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2022.175288","volume":"933","author":"YH Xu","year":"2022","unstructured":"Xu YH, Jiang ZS, Chen XW. Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulations. Eur J Pharmacol. 2022;933:12. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175288.","journal-title":"Eur J Pharmacol"},{"key":"3118_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbr.2020.113041","volume":"399","author":"KA Sullivan","year":"2021","unstructured":"Sullivan KA, Grant CV, Jordan KR, Vickery SS, Pyter LM. Voluntary wheel running ameliorates select paclitaxel chemotherapy-induced sickness behaviors and associated melanocortin signaling. Behav Brain Res. 2021;399:12. https:\/\/doi.org\/10.1016\/j.bbr.2020.113041.","journal-title":"Behav Brain Res"},{"key":"3118_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.expneurol.2019.113121","volume":"324","author":"NP Staff","year":"2020","unstructured":"Staff NP, Fehrenbacher JC, Caillaud M, Damaj MI, Segal RA, Rieger S. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of <i>in vitro<\/i> and <i>in vivo<\/i> findings using rodent and human model systems. Exp Neurol. 2020;324:10. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113121.","journal-title":"Exp Neurol"},{"key":"3118_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/ijn.S195375","volume":"14","author":"MJ Wang","year":"2019","unstructured":"Wang MJ, Chen LQ, Huang W, Jin MJ, Wang QM, Gao ZG, et al. Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes. Int J Nanomed. 2019;14:1385\u2013400. https:\/\/doi.org\/10.2147\/ijn.S195375.","journal-title":"Int J Nanomed"},{"issue":"5","key":"3118_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1208\/s12249-019-1413-0","volume":"20","author":"XZ Yin","year":"2019","unstructured":"Yin XZ, Cao XL, Li JQ, Cheng X, Cheng G, Zou MJ, et al. A novel surfactant-free O\/O paclitaxel ointment for the topical treatment of psoriasis. AAPS PharmSciTech. 2019;20(5):212. https:\/\/doi.org\/10.1208\/s12249-019-1413-0.","journal-title":"AAPS PharmSciTech"},{"key":"3118_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejpb.2023.02.007","volume":"185","author":"WX Liu","year":"2023","unstructured":"Liu WX, Pan WX, Zou MJ, Jin SC, Mi R, Cheng G, et al. Tacrolimus and paclitaxel co-loaded O\/O ointment without surfactant: Synergistic combinations for the treatment of psoriasis. Eur J Pharm Biopharm. 2023;185:28\u201343. https:\/\/doi.org\/10.1016\/j.ejpb.2023.02.007.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3118_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaad.2002.12.002","volume":"50","author":"M Lebwohl","year":"2004","unstructured":"Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50(3):416\u201330. https:\/\/doi.org\/10.1016\/j.jaad.2002.12.002.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3118_CR29","doi-asserted-by":"publisher","first-page":"e52445","DOI":"10.7759\/cureus.52445","volume":"16","author":"MZ Sarwar","year":"2024","unstructured":"Sarwar MZ, Khan NH, Beg MMA, Ankolvi NMJ, Osmonaliev K. The management of plaque psoriasis with halobetasol and tacrolimus combination therapy versus calcipotriol monotherapy: a case report. Cureus. 2024;16(1):e52445. https:\/\/doi.org\/10.7759\/cureus.52445.","journal-title":"Cureus"},{"issue":"4","key":"3118_CR30","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s10787-023-01257-2","volume":"31","author":"R Sreya","year":"2023","unstructured":"Sreya R, Nene S, Pathade V, Singh SB, Srivastava S. Emerging trends in combination strategies with phototherapy in advanced psoriasis management. Inflammopharmacology. 2023;31(4):1761\u201378. https:\/\/doi.org\/10.1007\/s10787-023-01257-2.","journal-title":"Inflammopharmacology"},{"issue":"4","key":"3118_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/03000605241247702","volume":"52","author":"J Li","year":"2024","unstructured":"Li J, Wang SY, Li XD, Han Y. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature. J Int Med Res. 2024;52(4):8. https:\/\/doi.org\/10.1177\/03000605241247702.","journal-title":"J Int Med Res"},{"key":"3118_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103103","volume":"68","author":"H Jain","year":"2022","unstructured":"Jain H, Geetanjali D, Dalvi H, Bhat A, Godugu C, Srivastava S. Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis. J Drug Deliv Sci Technol. 2022;68: 103103. https:\/\/doi.org\/10.1016\/j.jddst.2022.103103.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3118_CR33","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jdv.17113","volume":"35","author":"MG Lebwohl","year":"2021","unstructured":"Lebwohl MG, Stein Gold L, Papp K, Han G, Pariser DM, Lin T, et al. Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%\/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study. J Eur Acad Dermatol Venereol. 2021;35(5):1152\u201360. https:\/\/doi.org\/10.1111\/jdv.17113.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"3118_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4155\/tde.15.83","volume":"7","author":"M Davidovich-Pinhas","year":"2016","unstructured":"Davidovich-Pinhas M. Oleogels: a promising tool for delivery of hydrophobic bioactive molecules. Ther Deliv. 2016;7(1):1\u20133. https:\/\/doi.org\/10.4155\/tde.15.83.","journal-title":"Ther Deliv"},{"issue":"1\u20132","key":"3118_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijpharm.2009.12.045","volume":"388","author":"K Iwanaga","year":"2010","unstructured":"Iwanaga K, Sumizawa T, Miyazaki M, Kakemi M. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds. Int J Pharm. 2010;388(1\u20132):123\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.12.045.","journal-title":"Int J Pharm"},{"issue":"4","key":"3118_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/03639045.2013.828219","volume":"40","author":"K Rehman","year":"2014","unstructured":"Rehman K, Zulfakar MH. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm. 2014;40(4):433\u201340. https:\/\/doi.org\/10.3109\/03639045.2013.828219.","journal-title":"Drug Dev Ind Pharm"},{"key":"3118_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2019.104461","volume":"148","author":"P Charoensumran","year":"2020","unstructured":"Charoensumran P, Ajiro H. Controlled release of testosterone by polymer-polymer interaction enriched organogel as a novel transdermal drug delivery system: Effect of limonene\/PG and carbon-chain length on drug permeability. React Funct Polym. 2020;148: 104461. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2019.104461.","journal-title":"React Funct Polym"},{"issue":"1","key":"3118_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1208\/s12249-022-02481-9","volume":"24","author":"ZHF Al-Saedi","year":"2022","unstructured":"Al-Saedi ZHF, Salih ZT, Ahmed KK, Ahmed RA, Jasim SA. Formulation and characterization of oleogel as a topical carrier of Azithromycin. AAPS PharmSciTech. 2022;24(1):10. https:\/\/doi.org\/10.1208\/s12249-022-02481-9.","journal-title":"AAPS PharmSciTech"},{"key":"3118_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijbiomac.2024.135785","volume":"280","author":"YY Gu","year":"2024","unstructured":"Gu YY, Xu WW, Guo YJ, Gao YF, Zhu J. Development and characterization of tilapia skin collagen-inulin oleogel as the potential fat substitute in beef patty formulations. Int J Biol Macromol. 2024;280:17. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135785.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3118_CR40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s12325-023-02749-x","volume":"41","author":"MT Pradilla","year":"2024","unstructured":"Pradilla MT, Alvarez E, Novoa M, Lozano I, Trujillo M. Oleogel-S10 in dystrophic epidermolysis bullosa: a case series evaluating the impact on wound burden over two years. Adv Ther. 2024;41(2):867\u201377. https:\/\/doi.org\/10.1007\/s12325-023-02749-x.","journal-title":"Adv Ther"},{"issue":"6","key":"3118_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s1773-2247(10)50078-9","volume":"20","author":"G Fetih","year":"2010","unstructured":"Fetih G. Meloxicam formulations for transdermal delivery: hydrogels versus organogels. J Drug Deliv Sci Technol. 2010;20(6):451\u20136. https:\/\/doi.org\/10.1016\/s1773-2247(10)50078-9.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3 Pt B","key":"3118_CR42","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar RS, Gudjonsson JE, Ward NL. Mouse models of psoriasis: a comprehensive review. J Invest Dermatol. 2022;142(3 Pt B):884\u201397. https:\/\/doi.org\/10.1016\/j.jid.2021.06.019.","journal-title":"J Invest Dermatol."},{"issue":"21","key":"3118_CR43","doi-asserted-by":"publisher","first-page":"eabm8478","DOI":"10.1126\/sciadv.abm8478","volume":"8","author":"AR Kirtane","year":"2022","unstructured":"Kirtane AR, Karavasili C, Wahane A, Freitas D, Booz K, Le DTH, et al. Development of oil-based gels as versatile drug delivery systems for pediatric applications. Sci Adv. 2022;8(21):eabm8478. https:\/\/doi.org\/10.1126\/sciadv.abm8478.","journal-title":"Sci Adv."},{"issue":"20","key":"3118_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/app.52300","volume":"139","author":"B Behera","year":"2022","unstructured":"Behera B, Patil V, Sagiri SS, Pal K, Ray SS. Span-60-based organogels as probable matrices for transdermal\/topical delivery systems (vol 125, pg 852, 2012). J Appl Polym Sci. 2022;139(20):1. https:\/\/doi.org\/10.1002\/app.52300.","journal-title":"J Appl Polym Sci"},{"issue":"1","key":"3118_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0973-8398.100118","volume":"6","author":"R Balasubramanian","year":"2012","unstructured":"Balasubramanian R, Damodar G, Sughir A. Oleogel: A promising base for transdermal formulations. Asian J Pharm. 2012;6(1):1\u20139. https:\/\/doi.org\/10.4103\/0973-8398.100118.","journal-title":"Asian J Pharm"},{"issue":"5","key":"3118_CR46","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ijmm.2017.2930","volume":"39","author":"Y Meng","year":"2017","unstructured":"Meng Y, Wang M, Xie X, Di T, Zhao J, Lin Y, et al. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice by inhibiting the maturation and activation of dendritic cells. Int J Mol Med. 2017;39(5):1101\u201310. https:\/\/doi.org\/10.3892\/ijmm.2017.2930.","journal-title":"Int J Mol Med"},{"issue":"8","key":"3118_CR47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s1995-7645(14)60113-9","volume":"7","author":"Y-J Dai","year":"2014","unstructured":"Dai Y-J, Li Y-Y, Zeng H-M, Liang X-A, Xie Z-J, Zheng Z-A, et al. Effect of Yinxieling decoction on PASI, TNF-\u03b1 and IL-8 in patients with psoriasis vulgaris. Asian Pac J Trop Med. 2014;7(8):668\u201370. https:\/\/doi.org\/10.1016\/s1995-7645(14)60113-9.","journal-title":"Asian Pac J Trop Med"},{"key":"3118_CR48","doi-asserted-by":"publisher","first-page":"104914","DOI":"10.1016\/j.jff.2021.104914","volume":"89","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang L, Xia K, Dai J, Huang J, Wang Y, et al. Effects of dietary selenium on immune function of spleen in mice. J Funct Foods. 2022;89:104914. https:\/\/doi.org\/10.1016\/j.jff.2021.104914.","journal-title":"J Funct Foods"},{"issue":"2","key":"3118_CR49","doi-asserted-by":"publisher","first-page":"e13606","DOI":"10.1111\/srt.13606","volume":"30","author":"L Bhat","year":"2024","unstructured":"Bhat L, Bhat SR, Ramakrishnan A, Amirthalingam M. Brilaroxazine lipogel displays antipsoriatic activity in imiquimod-induced mouse model. Skin Res Technol. 2024;30(2):e13606. https:\/\/doi.org\/10.1111\/srt.13606.","journal-title":"Skin Res Technol"},{"issue":"11","key":"3118_CR50","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.autrev.2022.103169","volume":"21","author":"B Kapoor","year":"2022","unstructured":"Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmun Rev. 2022;21(11):103169. https:\/\/doi.org\/10.1016\/j.autrev.2022.103169.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3118_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9(5): e96801. https:\/\/doi.org\/10.1371\/journal.pone.0096801.","journal-title":"PLoS ONE"},{"key":"3118_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-015-0538-7","volume":"17","author":"HA Azim","year":"2015","unstructured":"Azim HA, Peccatori FA, Broh\u00e9e S, Branstetter D, Loi S, Viale G, et al. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy. Breast Cancer Res. 2015;17:24. https:\/\/doi.org\/10.1186\/s13058-015-0538-7.","journal-title":"Breast Cancer Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03118-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:46:45Z","timestamp":1751906805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3118"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03118-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"127"}}